A. Ranieri

Do Prognostic Parameters of Remission versus Relapse after Bacillus Calmette–Guérin (BCG) Immunotherapy Exist? Analysis of a Quarter Century of Literature

Primary vesical actinomycosis: A case report and literature review

BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer

Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

Photodynamic therapy and anti-tumour immunity

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

Actinomycosis: etiology, clinical features, diagnosis, treatment, and management

Preliminary European Results of Local Microwave Hyperthermia and Chemotherapy Treatment in Intermediate or High Risk Superficial Transitional Cell Carcinoma of the Bladder

Assessment of Eco-friendly Gases for Electrical Insulation to Replace the Most Potent Industrial Greenhouse Gas SF₆

Current Challenges and Perspectives in Resistive Gaseous Detectors: a manifesto from RPC 2012

Multicentric Study Comparing Intravesical Chemotherapy Alone and With Local Microwave Hyperthermia for Prophylaxis of Recurrence of Superficial Transitional Cell Carcinoma

Intravesical Instillation of Mitomycin-C in 242 Patients with Superficial Bladder Cancer at High Risk of Recurrence: Long-Term Results

Primary actinomycosis of the urachus

Low Dose Pasteur Bacillus Calmette-Guerin Regimen in Stage T1, Grade 3 Bladder Cancer Therapy

Resistive Plate Chambers in avalanche mode: a comparison between model predictions and experimental results